Brian Ginsberg, MB BCh
Medical Director, Acute Pain Therapy
Department / Division
Anesthesiology /
Anesthesiology-Regional Division
Address
DUMC 3094
Durham, NC 27710
Appointment Telephone
919-681-5396
Office Telephone
919-681-5396
Fax Telephone
919-681-7901
- MB BCh, University of the Witwatersrand School of Clinical Medicine (South Africa), 1975
- Anesthesiology, University of the Witwatersrand Faculty of Health Sciences (South Africa), 1979-1983
Clinical Interests
Acute pain, general/pediatric anesthesiology
Research Interests
My research activities, which are totally clinical and are closely intertwined with my clinical endeavors in the fields of acute pain management and pediatric anesthesia. Research in acute pain management will involve the introduction of both new drugs and techniques into the routine armamentarium of the acute pain team. Another beneficial avenue of research is the use of non invasive and lower cost technologies such as transmucosal fentanyl in the management of pain states. Studies will determine dosing equivalence and therapeutic effectiveness of transmucosal fentanyl. The focus of acute pain therapy is shifting from intermittent analgesia to around the clock medication The development of slow release formulations of potent opioids allows for the study of these agents to optimize postoperative pain. Continuous monitoring of the effectiveness of pain therapy is required to justify the time and expense of therapy. Studies are underway to determine patient satisfaction with these newer modalities of pain care.
One of the clinical challenges in pediatric anesthesia is to overcome some of the trauma associated with pediatric anesthesia. This entails the use of new pharmacological agents and psychological preparation of children prior to surgery.
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- Cadence Pharmaceuticals, Inc.
- Johnson & Johnson
- Pacira
- Pfizer Inc.
